STOCK TITAN

Morgan Stanley SEC Filings

MS NYSE

Welcome to our dedicated page for Morgan Stanley SEC filings (Ticker: MS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Morgan Stanley (NYSE: MS) SEC filings page on Stock Titan brings together the firm’s regulatory disclosures, including current reports on Form 8‑K and other registered securities information. These filings show how Morgan Stanley communicates material events such as quarterly and annual financial results, capital actions, regulatory capital developments and securities offerings.

Form 8‑K filings frequently cover the release of financial information for specific quarters and for the full year, with press releases and financial data supplements filed as exhibits. Other 8‑K reports describe changes in the firm’s Stress Capital Buffer under the Federal Reserve’s supervisory stress testing framework, providing context on Morgan Stanley’s U.S. Basel III Standardized Approach Common Equity Tier 1 capital requirements.

The filings also list the securities registered under Section 12(b) of the Securities Exchange Act of 1934, including common stock, multiple series of non‑cumulative preferred stock represented by depositary shares, and global medium‑term notes issued by Morgan Stanley or Morgan Stanley Finance LLC, with Morgan Stanley acting as guarantor for certain notes. Additional 8‑K filings describe the approval of forms of master notes for global medium‑term notes and related legal opinions and consents.

On Stock Titan, these SEC documents are updated as they are made available on EDGAR. AI‑powered summaries help explain the key points in lengthy filings, so users can quickly see what each 8‑K, 10‑K or 10‑Q addresses without reading every page. Investors can also use this page to monitor registered securities, preferred stock disclosures and other regulatory information related to Morgan Stanley.

Rhea-AI Summary

Morgan Stanley Finance LLC is offering $100,000 aggregate principal amount of Jump Securities with an Auto-Callable Feature linked to the S&P® 500 Futures 40% Intraday 4% Decrement VT Index (SPXF40D4). The notes are part of the Series A Global MTN program, are principal-at-risk and are fully and unconditionally guaranteed by Morgan Stanley.

Key economic terms:

  • Issue/Principal: $1,000 per security (minimum $1,000 denomination)
  • Pricing & Strike Date: 3 Jul 2025; Settlement: 9 Jul 2025; Maturity: 9 Jul 2030 (5-year tenor)
  • Automatic Early Redemption: single observation on 7 Jul 2026; if index ≥ 2,623.80 (100% of initial) investors receive $1,250 and the note terminates.
  • Upside at maturity: if not called and index > initial, payout = $1,000 + 350% × (index gain).
  • Principal protection: none. If final level < 50% of initial (1,311.90) investors lose 1% of principal per 1% index decline.
  • Estimated value on pricing date: $949.60 (≈ 94.96% of issue price) reflecting MS internal funding rate and structuring costs.
  • Secondary market: not exchange-listed; MS & Co. may provide limited liquidity.

Index characteristics: SPXF40D4 (launched Aug 2024) uses intraday rebalancing, a 40% volatility target, leverage up to 400%, and applies a 4% per-annum “decrement” drag, causing systematic under-performance versus a non-decrement version. Back-tested data prior to Aug 2024 is hypothetical.

Risk highlights:

  • Investors may lose up to 100% of principal.
  • Single early-call observation exposes holders to “re-investment risk” and caps upside at 25% (before fees/taxes).
  • Liquidity is dependent on MS & Co.; bid–offer likely at discount.
  • Credit exposure to Morgan Stanley; MSFL has no independent assets.
  • Tax treatment uncertain; expected to be prepaid financial contract, but IRS could disagree.

Cost & conflicts: Price to public equals face; advisory-fee accounts only. Net proceeds to MSFL are $997.50 per note; MS & Co. earns ~$2.50 structuring fee and may hedge positions. The note provides inexpensive term funding to Morgan Stanley while transferring market and decrement risk to investors.

For sophisticated investors comfortable with equity-index volatility, leverage and credit risk, the notes offer 3.5× participation above initial level and a 25% fixed premium if called, but the decrement drag, leverage-induced downside and lack of coupons make risk-adjusted return highly path-dependent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.82%
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC is offering $684,000 aggregate principal of Trigger Jump Securities due July 8, 2027. Each $1,000 note is linked to the worst performer of the Russell 2000, S&P 500 and EURO STOXX 50 indices and carries no coupons.

Pay-off profile:

  • Upside: If all three indices finish at or above their initial levels on the July 2, 2027 observation date, holders receive principal plus a fixed $340 upside payment (34%). Additional index gains are not shared.
  • Par: If any index is below its initial level but all three stay at or above 70 % of their initial levels, only principal is repaid.
  • Downside: If any index closes below its 70 % downside threshold, redemption equals principal times the worst performer’s percentage return, creating full downside exposure and potential total loss.

Key terms: strike & pricing date July 2, 2025; estimated value $983.70 (reflects structuring & hedging costs); sold in fee-based advisory accounts with no sales commission but up to $6.25 structuring fee; not exchange-listed; secondary liquidity, if any, only through Morgan Stanley & Co.

Principal risks include loss of principal, limited upside, credit risk of Morgan Stanley, market volatility, correlation risk among indices, liquidity constraints and uncertain tax treatment.

The small issuance size and short tenor make the offering immaterial to Morgan Stanley’s overall capital structure; it is designed for investors seeking a capped return with a 30 % buffer in exchange for uncapped downside beyond that level.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Morgan Stanley Finance LLC (MSFL) is offering $842,000 aggregate principal amount of Buffered Jump Securities with an Auto-Callable feature that mature on April 6, 2028 and are fully and unconditionally guaranteed by Morgan Stanley. The unsecured notes are linked to the worst performing of the Global X Silver Miners ETF (SIL) and the Global X Uranium ETF (URA). Each security has a stated principal of $1,000 and will be issued at par; investors pay a 3.15 % sales commission, leaving net proceeds of $968.50 per note and an estimated value at pricing of $955.10.

Key structural terms

  • Auto-call schedule: 27 monthly determination dates starting Jan 2 2026. If both ETFs close at or above their respective call thresholds (100 % of initial levels) on any determination date, the note is automatically redeemed for the preset amount shown in the schedule—equivalent to ~21.65 % simple annualized return—terminating further payments.
  • Payment at maturity: If not called and the final level of each ETF ≥ call threshold, holders receive $1,595.375 (59.54 % absolute return). If either ETF finishes ≥ its 85 % buffer but < its call threshold, repayment is limited to principal. If either ETF finishes < its buffer, repayment is reduced dollar-for-dollar beyond the 15 % buffer, subject to a minimum payment of 15 % of principal ($150).
  • Risk profile: Investors forgo dividends and all upside beyond the fixed jump payments; downside is uncapped (other than the minimum $150). The note’s performance is driven solely by the worst performer of the two ETFs, eliminating diversification benefits.
  • Credit & liquidity: Payments depend on Morgan Stanley’s creditworthiness. The notes will not be listed; MS&Co. may provide a secondary market but is not obliged to do so. Secondary prices will reflect bid/ask spreads, issuer credit spreads, and may be materially below par.
  • Sector concentration: Investors assume additional volatility linked to silver-mining and uranium-related equities, each exposed to commodity price swings, regulatory shifts, and cyclical demand.

Cost considerations & conflicts

  • The internal funding rate and embedded hedging/structuring costs reduce investor economics; the estimated value is 4.49 % below issue price.
  • MS&Co. is both selling agent and calculation agent, creating potential conflicts in valuation, adjustments, and secondary pricing.

Suitability: The product targets investors comfortable with principal-at-risk exposure, no current income, complex tax treatment, limited liquidity, and concentrated commodity risk, in exchange for a predefined jump return and 15 % downside buffer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Morgan Stanley Finance LLC, fully guaranteed by Morgan Stanley, is offering Contingent Income Memory Auto-Callable Securities maturing 16 July 2030. The $1,000-denominated notes combine a debt component with an equity-linked payoff tied to the Nasdaq Biotechnology Index (NBI), Amazon.com, Inc. (AMZN) and Alphabet Inc. (GOOGL). All cash flows depend on the worst-performing underlier.

Key economic terms:

  • Annual contingent coupon: 16.00% (paid quarterly ≈ $40/period) but only if the closing level of each underlier is ≥ 85 % of its initial level (“coupon barrier”) on the scheduled observation date. Missed coupons accrue and may be paid later if the barrier is met (“memory” feature).
  • Automatic early redemption: From 13 Jul 2026 onward, if on any determination date each underlier is ≥ 100 % of its initial level (“call threshold”), investors receive principal plus the current and any accrued coupons; the note then terminates.
  • Payment at maturity: • If every underlier ≥ 100 % of initial, principal is repaid plus the final (and any accrued) coupon. • Otherwise, payoff = $1,000 × (final level / initial level) of the worst underlier, exposing investors to a 1 % loss of principal for each 1 % decline; repayment may be zero.
  • Issue price: $1,000; estimated value: ≈ $956.70 (reflecting issuer costs and an internal funding rate advantageous to Morgan Stanley).
  • Schedule: pricing 11 Jul 2025; issue 16 Jul 2025; 18 observation/redemption dates; not exchange-listed.
  • Credit risk: unsecured obligations of MSFL; repayment depends solely on Morgan Stanley’s creditworthiness.

Investor considerations: The structure offers potential double-digit income in low-rate environments, but coupons and principal are contingent on three correlated assets. Investors face full downside exposure to the worst performer, possible loss of all coupons, early-call reinvestment risk, limited liquidity and tax uncertainty. The note suits risk-tolerant investors seeking enhanced income and able to absorb equity-like losses within a credit-linked note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many Morgan Stanley (MS) SEC filings are available on StockTitan?

StockTitan tracks 3214 SEC filings for Morgan Stanley (MS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Morgan Stanley (MS)?

The most recent SEC filing for Morgan Stanley (MS) was filed on July 8, 2025.